Santé log2d
Better Choice Company Board of Directors Approves Up to 55% Annual Royalty Distribution Plan from its Halo Brand
Michael Young, Chairman of Better Choice, commented, “This unique royalty distribution plan underscores Better Choice’s commitment to delivering long-term value to our shareholders from our Halo brand ...
Santé log2d
Recover Red Debuts Innovative PEMF+ Grounding Mat, Transforming At-Home Therapy
Recover Red, a leader in advanced wellness technology, has launched the PEMF+ Grounding Mat, a next-generation therapy device ...
Santé log2d
Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer
Genmab A/S (Nasdaq: GMAB) announced today updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart sesutecan (Rina-S ®), an investigational folate receptor-alpha (FRα)-targeted, ...
Santé log2d
Alpha Bites Gummies: The Science, Ingredients, and Real User Experiences Behind This Natural Male Vitality Formula
Alpha Bites Gummies are designed for men seeking to enhance their vitality, stamina, and performance naturally and ...
Santé log2d
Wellinks and CareAbout Health Partner to Expand Value-Based COPD Management in New Jersey and Florida
CareAbout will incorporate Wellinks’ value-based COPD management programs, which include virtual pulmonary rehabilitation, remote monitoring, and ongoing care management, all designed to improve ...
Santé log2d
New Research Reveals One Million More Glaucoma Cases Than Previously Believed — Glaucoma Research Foundation Urges Early Screening
SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- The Glaucoma Research Foundation (GRF) is launching a national awareness campaign, “Your Eyes Say Thanks,” to educate the public on the importance of ...
Santé log2d
Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes
PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...
Santé log2d
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced positive long-term data ...
Santé log2d
Lytus Technologies announces 24% Revenue Growth for H1 FY2025
Mumbai, India, March 17, 2025 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT), a leader in platform services and next-generation technology, today announced its consolidated ...
Santé log2d
OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants
OXFORD, United Kingdom and NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., the pioneering company transforming organ transplantation and care with innovative technology, has announced a new ...
Santé log2d
Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering
Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has ...
Santé log2d
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
The use of CLPH-511 in acute hemorrhage is currently being investigated in a Phase 2/3 adaptive design study, titled “Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets ...